Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Massachusetts
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Massachusetts
4 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1623, Boston
- Site Number - 1625, Worcester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Massachusetts General Hospital- Site Number : 8400009, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Burlington
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Beth Israel Deaconess Medical Center, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.